Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic
Abstract Aims CKD‐HF patients suffer excess hospitalization and mortality, often under‐treated with life‐prolonging medications due to fear of worsening renal function and hyperkalaemia. Yet, role of inter‐disciplinary working in improving therapy is unknown, which this study aims to investigate. Me...
Main Authors: | Mai Nguyen, Samir Rumjaun, Racquel Lowe‐Jones, Irina Chis Ster, Giuseppe Rosano, Lisa Anderson, Debasish Banerjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12796 |
Similar Items
-
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
by: Nappi J, et al.
Published: (2011-06-01) -
The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K+-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure
by: Daniel Murphy, et al.
Published: (2021-07-01) -
Angiotensin receptor-neprilysin inhibitor in patients with heart failure and chronic kidney disease
by: In-Jeong Cho, et al.
Published: (2021-12-01) -
Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
by: A. M. Esayan, et al.
Published: (2018-04-01) -
Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
by: Namrata Singhania, et al.
Published: (2020-11-01)